{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:57:10Z","timestamp":1776214630713,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503156 81601347"],"award-info":[{"award-number":["81503156 81601347"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270836"],"award-info":[{"award-number":["81270836"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2014A030310096"],"award-info":[{"award-number":["2014A030310096"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Public Welfare Research and Capacity Building Fund of Guangdong","award":["2016A020218006"],"award-info":[{"award-number":["2016A020218006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1111\/jcpt.12480","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T05:02:50Z","timestamp":1480050170000},"page":"93-97","source":"Crossref","is-referenced-by-count":16,"title":["Dynamic effects of<i>CYP3A5<\/i>polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients"],"prefix":"10.1155","volume":"42","author":[{"given":"P.","family":"Chen","sequence":"first","affiliation":[{"name":"Pharmacy Department; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[{"name":"Center of Reproductive Medicine; The Sixth Affiliated Hospital of Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[{"name":"Organ Transplant Center; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Deng","sequence":"additional","affiliation":[{"name":"Pharmacy Department; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Fu","sequence":"additional","affiliation":[{"name":"Organ Transplant Center; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Chen","sequence":"additional","affiliation":[{"name":"Pharmacy Department; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences; Institute of Clinical Pharmacology; Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Chen","sequence":"additional","affiliation":[{"name":"Pharmacy Department; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wang","sequence":"additional","affiliation":[{"name":"Organ Transplant Center; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"10.1111\/jcpt.12480-BIB0001|jcpt12480-cit-0001","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1517\/14656566.9.4.635","article-title":"The role of tacrolimus in renal transplantation","volume":"9","author":"Bowman","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/jcpt.12480-BIB0002|jcpt12480-cit-0002","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation","volume":"43","author":"Staatz","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12480-BIB0003|jcpt12480-cit-0003","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","article-title":"Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference","volume":"31","author":"Wallemacq","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1111\/jcpt.12480-BIB0004|jcpt12480-cit-0004","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00007890-199610150-00005","article-title":"An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group","volume":"62","author":"Laskow","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/jcpt.12480-BIB0005|jcpt12480-cit-0005","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1373\/clinchem.2004.043950","article-title":"Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry","volume":"51","author":"Brown","year":"2005","journal-title":"Clin Chem"},{"key":"10.1111\/jcpt.12480-BIB0006|jcpt12480-cit-0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00228-012-1296-4","article-title":"Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients","volume":"69","author":"Han","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12480-BIB0007|jcpt12480-cit-0007","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1373\/clinchem.2005.050047","article-title":"Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus","volume":"51","author":"Kamdem","year":"2005","journal-title":"Clin Chem"},{"key":"10.1111\/jcpt.12480-BIB0008|jcpt12480-cit-0008","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/phgs.5.3.243.29833","article-title":"Genetic variability in CYP3A5 and its possible consequences","volume":"5","author":"Xie","year":"2004","journal-title":"Pharmacogenomics"},{"key":"10.1111\/jcpt.12480-BIB0009|jcpt12480-cit-0009","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-200112000-00005","article-title":"The genetic determinants of the CYP3A5 polymorphism","volume":"11","author":"Hustert","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1111\/jcpt.12480-BIB0010|jcpt12480-cit-0010","doi-asserted-by":"crossref","first-page":"E272","DOI":"10.1111\/ctr.12101","article-title":"Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism-a prospective, randomized, controlled study","volume":"27","author":"Chen","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1111\/jcpt.12480-BIB0011|jcpt12480-cit-0011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trre.2007.09.002","article-title":"Pharmacogenetics in solid organ transplantation: current status and future directions","volume":"22","author":"Jonge","year":"2008","journal-title":"Transplant Rev"},{"key":"10.1111\/jcpt.12480-BIB0012|jcpt12480-cit-0012","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/tpj.2014.38","article-title":"Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies","volume":"15","author":"Rojas","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/jcpt.12480-BIB0013|jcpt12480-cit-0013","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0166-0934(91)90126-K","article-title":"An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents","volume":"34","author":"Loparev","year":"1991","journal-title":"J Virol Methods"},{"key":"10.1111\/jcpt.12480-BIB0014|jcpt12480-cit-0014","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00228-008-0577-4","article-title":"Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem","volume":"65","author":"Wang","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12480-BIB0015|jcpt12480-cit-0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2710.2008.00879.x","article-title":"Frequencies of CYP3A5 genotypes and haplotypes in a Korean population","volume":"33","author":"Park","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12480-BIB0016|jcpt12480-cit-0016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00228-003-0594-2","article-title":"CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations","volume":"59","author":"Balram","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12480-BIB0017|jcpt12480-cit-0017","doi-asserted-by":"crossref","first-page":"e86206","DOI":"10.1371\/journal.pone.0086206","article-title":"Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR genetic polymorphisms on tacrolimus metabolism in Chinese renal transplant recipients","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1111\/jcpt.12480-BIB0018|jcpt12480-cit-0018","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00228-015-1990-0","article-title":"Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation","volume":"72","author":"Yaowakulpatana","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12480-BIB0019|jcpt12480-cit-0019","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/clpt.2009.210","article-title":"Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients","volume":"86","author":"Zhao","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12480-BIB0020|jcpt12480-cit-0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/11318080-000000000-00000","article-title":"Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients","volume":"48","author":"Benkali","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12480-BIB0021|jcpt12480-cit-0021","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/clpt.2012.109","article-title":"In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients","volume":"92","author":"Jonge","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12480-BIB0022|jcpt12480-cit-0022","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/FTD.0b013e31829f1ab8","article-title":"Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose","volume":"36","author":"Bergmann","year":"2014","journal-title":"Ther Drug Monit"},{"key":"10.1111\/jcpt.12480-BIB0023|jcpt12480-cit-0023","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/FTD.0b013e318279dfd2","article-title":"Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation","volume":"35","author":"Tempestilli","year":"2013","journal-title":"Ther Drug Monit"},{"key":"10.1111\/jcpt.12480-BIB0024|jcpt12480-cit-0024","first-page":"30","article-title":"Relationship among changes in hematocrit, albumin and corticosteroid dose on the disposition of tacrolimus during the first six months following renal transplantation","volume":"54","author":"Robles-Piedras","year":"2011","journal-title":"Proc West Pharmacol Soc"},{"key":"10.1111\/jcpt.12480-BIB0025|jcpt12480-cit-0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0041-1345(98)01633-9","article-title":"Low systemic exposure to tacrolimus correlates with acute rejection","volume":"31","author":"Undre","year":"1999","journal-title":"Transpl Proc"},{"key":"10.1111\/jcpt.12480-BIB0026|jcpt12480-cit-0026","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/FTD.0b013e3181a8f02a","article-title":"Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection","volume":"31","author":"Borobia","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1111\/jcpt.12480-BIB0027|jcpt12480-cit-0027","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/PPA.S54922","article-title":"Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational study","volume":"8","author":"Sabbatini","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1111\/jcpt.12480-BIB0028|jcpt12480-cit-0028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12480","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12480\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:33Z","timestamp":1671818553000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12480","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,25]]}}}